Cisapride provides symptomatic relief in functional dyspepsia associated with gastric myoelectrical abnormality

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 8, 2000, Pages 1041-1047

  Chen, J D Z ^a   Ke, M Y ^a   Lin, X M ^a   Wang, Z ^a   Zhang, M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CISAPRIDE;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPEPSIA; ELECTROGASTROGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MYOELECTRICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CISAPRIDE; DYSPEPSIA; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; POSTPRANDIAL PERIOD; STOMACH; TREATMENT OUTCOME;

EID: 0033866680     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00801.x     Document Type: Article

References (31)

1. 1 Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
2. 2 Holtmann G, Talley NJ. Functional dyspepsia: current treatment recommendations. Drugs 1993; 45: 918-30.
3. 3 Barbara L, Camilleri M, Corinaldesi R, et al. Definition and investigation of dyspepsia: consensus of an international ad hoc working party. Dig Dis Sci 1989; 34: 1272-6.
4. 4 Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Intern 1991; 4: 145-60.
5. 5 Malagelada JR, Azpiroz F, Mearin F. Gastroduodenal motor function in health and disease. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease, 5th edn. Philadelphia: W.B. Saunders, 1993: 486-508.
6. 6 Mearin F, Morera M, Cucala M, et al. Symptoms in functional dyspepsia: relationship to gastroduodenal inflammation and dysmotility, duodenogastric reflux and Helicobacter pylori. Gastroenterology 1991; 100: A122(Abstract).
7. 7 Thor P, Lorens K, Tabor S, et al. Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with nonulcer dyspepsia. J Physiol Pharmacol 1996; 47: 469-76.
8. 8 Koch KL, Stern RM. Functional disorders of the stomach. Semin Gastro Dis 1996; 7: 185-95.
9. 9 Pfaffenbach B, Adamek RJ, Bartholomäus C, et al. Gastric dysrhythmias and delayed gastric emptying in patients with functional dyspepsia. Dig Dis Sci 1997; 42: 2094-9.
10. 10 Löpez Gastön AR, de Löpez Luise GA, Sarmiento A. Electrogastrografia y vaciameiento gastrico en pacientes con dispepsia no organiza. Acta Gastroenterol Latinoamer 1996; 26: 285-92.
11. 11 Parkman HP, Miller MA, Trate D, et al. Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia. J Clin Gastroenterol 1997; 24: 214-9.
12. 12 Lin X, Levanon D, Chen JDZ. Impaired postprandial gastric slow waves in patients with functional dyspepsia. Dig Dis Sci 1998; 43: 1678-84.
13. 13 Physicians' Desk Reference, 52nd edn. Montvale, NJ: Medical Economics Co, 1998: 1308-9.
14. 14 Edelbroek M, Schuurkes J, De Ridder W, et al. Effect of cisapride on myoelectrical and motor response of antropyloroduodenal region during intraduodenal lipid and antral tachygastria in conscious dog. Dig Dis Sci 1995; 40: 901-11.
15. 15 Rothstein RD, Alavi A, Reynolds JC. Electrogastrography in patients with gastroparesis and effect of long-term cisapride. Dig Dis Sci 1993; 38: 1518-24.
16. 16 Wiseman LR, Faulds D. Cisapride: an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal disorders. Drugs 1994; 47: 116-52.
17. 17 Patel R, Launspach J, Soffer E. Effects of cisapride on salivary production in normal subjects. Dig Dis Sci 1996; 41: 480-4.
18. 18 Chen J. A computerized data analysis system for electrogastrogram. Comp Biol Med 1992; 22: 45-58.
19. 19 Chen JDZ, Lin Z, Pan J, et al. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 1996; 41: 1538-45.
20. 20 Abell TL, Camilleri M, Hench VS, et al. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol 1991; 3: 163-7.
21. 21 Koch KL. Gastric dysrhythmias and the current status of electrogastrography. Pract Gastroenterol 1989; 13: 37-44.
22. 22 You CH, Chey WY. Study of electromechanical activity of the stomach in human and in dogs with particular attention to tachygastria. Gastroenterology 1984; 86: 1460-8.
23. 23 Smout AJPM, van der Schee EJ, Grashuis JL. What is measured in electrogastrography? Dig Dis Sci 1980; 25: 179-87.
24. 24 Familoni BO, Bowes KL, Kingma YJ, et al. Can transcutaneous recordings detect gastric electrical abnormalities? Gut 1991; 32: 141-6.
25. 25 Chen J, Schirmer BD, McCallum RW. Serosal and cutaneous recordings of gastric myoelectrical activity in patients with gastroparesis. Am J Physiol 1994; 266: G90-8.
26. 26 Qian L, Peters LJ, Chen JDZ. Effects of electroacupunture on gastric migrating myoelectrical complex in dogs. Dig Dis Sci 1999; 44: 56-62.
27. 27 Chen J, McCallum RW. Gastric slow wave abnormalities in patients with gastroparesis. Am J Gastroenterol 1992; 87: 477-82.
28. 28 Tomita R, Takizawa H, Tanjoh K. Physiologic effects of cisapride on gastric emptying after pylorus-preserving gastrectomy for early gastric cancer. World J Surg 1998; 22: 35-41.
29. 29 Goldhill DR, Toner CC, Tarling MM, et al. Double-blind, randomized study of the effect of cisapride on gastric emptying in critically ill patients. Crit Care Med 1997; 25: 447-51.
30. 30 Brummer RJM, Schoenmakers EAJM, Kemerink GJ, et al. The effect of a single rectal dose of cisapride on delayed gastric emptying. Aliment Pharmacol Ther 1997; 11: 781-5.
31. 31 Cucchiara S, Minella R, Riezzo G, et al. Reversal of gastric electrical dysrhythmias by cisapride in children with functional dyspepsia. Report of three cases. Dig Dis Sci 1992; 37: 1136-40.